Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Diluted Average) (2023 - 2025)

Volitionrx's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $106.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 23.46% year-over-year to $106.8 million; the TTM value through Dec 2025 reached $106.8 million, up 23.46%, while the annual FY2025 figure was $106.8 million, 23.46% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $106.8 million in Q4 2025 per VNRX's latest filing, down from $108.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $108.2 million in Q3 2025 to a low of $71.2 million in Q4 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $90.8 million, with a median of $86.5 million recorded in 2024.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 28.57% in 2025 against a maximum downside of 17.79% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $71.2 million in 2023, then grew by 21.47% to $86.5 million in 2024, then grew by 23.46% to $106.8 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Shares Outstanding (Diluted Average) are $106.8 million (Q4 2025), $108.2 million (Q3 2025), and $99.6 million (Q2 2025).